Telix Pharmaceuticals | TLX - Ebit

Stock Price
9.85
Daily Change
-0.28 -2.76%
Monthly
-10.54%
Yearly
-65.99%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD37.44M in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Mayne Pharma AUD -16.2M 13.2M Jun/2024
Medical Developments International AUD -12.12M 3.97M Jun/2023
Mesoblast USD -42.11M 21.69M Jun/2025
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -19.93M 12.02M Jun/2023
Polynovo AUD 840K 147K Jun/2024
PYC Therapeutics AUD -25.84M 3M Dec/2024
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
ResMed USD 497.6M 35.25M Dec/2025
Sonic Healthcare AUD 423.94M 80.3M Dec/2024